vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与VIRCO MFG CORPORATION（VIRC）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是VIRCO MFG CORPORATION的1.6倍（$75.5M vs $47.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -42.3%），VIRCO MFG CORPORATION自由现金流更多（$24.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
维尔科制造公司（简称Virco）是总部位于美国加利福尼亚州托伦斯的家具制造商，主打教育场景家具产品，核心产品涵盖学生课桌、活动桌、校园及办公座椅、电脑台、轻质折叠桌与布艺沙发椅等。
PBYI vs VIRC — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$47.6M
营收增速更快
PBYI
高出70.1%
-42.3%
自由现金流更多
VIRC
多$10.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
5.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $47.6M |
| 净利润 | — | $-1.3M |
| 毛利率 | 69.3% | 38.0% |
| 营业利润率 | 22.7% | -3.6% |
| 净利率 | — | -2.8% |
| 营收同比 | 27.7% | -42.3% |
| 净利润同比 | — | -115.8% |
| 每股收益（稀释后） | $0.26 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIVIRC
| Q4 25 | $75.5M | $47.6M | ||
| Q3 25 | $54.5M | $92.1M | ||
| Q2 25 | $52.4M | $33.8M | ||
| Q1 25 | $46.0M | $28.5M | ||
| Q4 24 | $59.1M | $82.6M | ||
| Q3 24 | $80.5M | $108.4M | ||
| Q2 24 | $47.1M | $46.7M | ||
| Q1 24 | $43.8M | $42.6M |
净利润PBYIVIRC
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $8.8M | $10.2M | ||
| Q2 25 | $5.9M | $732.0K | ||
| Q1 25 | $3.0M | $-5.7M | ||
| Q4 24 | — | $8.4M | ||
| Q3 24 | $20.3M | $16.8M | ||
| Q2 24 | $-4.5M | $2.1M | ||
| Q1 24 | $-4.8M | $-2.3M |
毛利率PBYIVIRC
| Q4 25 | 69.3% | 38.0% | ||
| Q3 25 | 77.7% | 44.4% | ||
| Q2 25 | 76.5% | 47.5% | ||
| Q1 25 | 77.1% | 26.2% | ||
| Q4 24 | 76.4% | 44.4% | ||
| Q3 24 | 63.9% | 46.3% | ||
| Q2 24 | 77.4% | 43.5% | ||
| Q1 24 | 75.5% | 37.7% |
营业利润率PBYIVIRC
| Q4 25 | 22.7% | -3.6% | ||
| Q3 25 | 17.6% | 16.7% | ||
| Q2 25 | 12.7% | -0.3% | ||
| Q1 25 | 8.7% | -28.5% | ||
| Q4 24 | 22.6% | 13.5% | ||
| Q3 24 | 27.4% | 20.2% | ||
| Q2 24 | -4.6% | 6.4% | ||
| Q1 24 | -5.3% | -6.5% |
净利率PBYIVIRC
| Q4 25 | — | -2.8% | ||
| Q3 25 | 16.2% | 11.1% | ||
| Q2 25 | 11.2% | 2.2% | ||
| Q1 25 | 6.5% | -20.1% | ||
| Q4 24 | — | 10.2% | ||
| Q3 24 | 25.2% | 15.5% | ||
| Q2 24 | -9.6% | 4.6% | ||
| Q1 24 | -11.0% | -5.5% |
每股收益（稀释后）PBYIVIRC
| Q4 25 | $0.26 | $-0.08 | ||
| Q3 25 | $0.17 | $0.65 | ||
| Q2 25 | $0.12 | $0.05 | ||
| Q1 25 | $0.06 | $-0.37 | ||
| Q4 24 | $0.40 | $0.52 | ||
| Q3 24 | $0.41 | $1.04 | ||
| Q2 24 | $-0.09 | $0.13 | ||
| Q1 24 | $-0.10 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $3.9M |
| 股东权益账面价值 | $130.3M | $113.6M |
| 总资产 | $216.3M | $181.5M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.03× |
8季度趋势，按日历期对齐
现金及短期投资PBYIVIRC
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | $5.3M |
总债务PBYIVIRC
| Q4 25 | $22.7M | $3.9M | ||
| Q3 25 | $34.0M | $4.0M | ||
| Q2 25 | $45.3M | $4.1M | ||
| Q1 25 | $56.7M | $4.1M | ||
| Q4 24 | $68.0M | $4.2M | ||
| Q3 24 | $79.3M | $4.3M | ||
| Q2 24 | $90.7M | $7.0M | ||
| Q1 24 | $102.0M | $4.4M |
股东权益PBYIVIRC
| Q4 25 | $130.3M | $113.6M | ||
| Q3 25 | $115.3M | $115.4M | ||
| Q2 25 | $104.7M | $105.6M | ||
| Q1 25 | $97.1M | $109.3M | ||
| Q4 24 | $92.1M | $115.9M | ||
| Q3 24 | $71.1M | $107.8M | ||
| Q2 24 | $48.5M | $91.6M | ||
| Q1 24 | $51.0M | $91.2M |
总资产PBYIVIRC
| Q4 25 | $216.3M | $181.5M | ||
| Q3 25 | $202.9M | $198.6M | ||
| Q2 25 | $194.9M | $183.8M | ||
| Q1 25 | $196.2M | $191.9M | ||
| Q4 24 | $213.3M | $210.1M | ||
| Q3 24 | $220.7M | $216.3M | ||
| Q2 24 | $205.0M | $152.5M | ||
| Q1 24 | $214.1M | $146.4M |
负债/权益比PBYIVIRC
| Q4 25 | 0.17× | 0.03× | ||
| Q3 25 | 0.30× | 0.03× | ||
| Q2 25 | 0.43× | 0.04× | ||
| Q1 25 | 0.58× | 0.04× | ||
| Q4 24 | 0.74× | 0.04× | ||
| Q3 24 | 1.12× | 0.04× | ||
| Q2 24 | 1.87× | 0.08× | ||
| Q1 24 | 2.00× | 0.05× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $24.5M |
| 自由现金流率自由现金流/营收 | 19.1% | 51.5% |
| 资本支出强度资本支出/营收 | 0.0% | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-4.3M |
8季度趋势，按日历期对齐
经营现金流PBYIVIRC
| Q4 25 | $14.4M | $25.8M | ||
| Q3 25 | $9.7M | $3.2M | ||
| Q2 25 | $14.1M | $-19.0M | ||
| Q1 25 | $3.6M | $-8.3M | ||
| Q4 24 | $15.6M | $33.5M | ||
| Q3 24 | $11.0M | $12.5M | ||
| Q2 24 | $1.0M | $-4.5M | ||
| Q1 24 | $11.2M | $4.7M |
自由现金流PBYIVIRC
| Q4 25 | $14.4M | $24.5M | ||
| Q3 25 | $9.7M | $1.8M | ||
| Q2 25 | $14.1M | $-21.5M | ||
| Q1 25 | $3.6M | $-9.2M | ||
| Q4 24 | $15.6M | $31.0M | ||
| Q3 24 | $11.0M | $10.7M | ||
| Q2 24 | $1.0M | $-5.6M | ||
| Q1 24 | — | $4.0M |
自由现金流率PBYIVIRC
| Q4 25 | 19.1% | 51.5% | ||
| Q3 25 | 17.7% | 2.0% | ||
| Q2 25 | 26.8% | -63.6% | ||
| Q1 25 | 7.7% | -32.4% | ||
| Q4 24 | 26.4% | 37.5% | ||
| Q3 24 | 13.7% | 9.8% | ||
| Q2 24 | 2.1% | -12.0% | ||
| Q1 24 | — | 9.5% |
资本支出强度PBYIVIRC
| Q4 25 | 0.0% | 2.7% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 7.2% | ||
| Q1 25 | 0.1% | 3.3% | ||
| Q4 24 | 0.0% | 3.0% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 2.3% | ||
| Q1 24 | 0.0% | 1.5% |
现金转化率PBYIVIRC
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 0.31× | ||
| Q2 25 | 2.41× | -26.00× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 3.98× | ||
| Q3 24 | 0.54× | 0.74× | ||
| Q2 24 | — | -2.11× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
